3929 POINT EDEN WAY, HAYWARD, CA
Investor Presentation
Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
Board Changes - Leon Chen and Joshua Wolfe Resign
Board Appointment - Ma. Fatima D. Francisco Joins Eikon Therapeutics Board
Reports First Quarter 2026 Financial Results and Provides Clinical Updates
Financial Results, Press Release
Amendment and Restatement of Certificate of Incorporation and Bylaws
Q2
Q1
FY 2025
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Certificate
Effectiveness Notice
Registration of Securities
Amended Registration Statement for Securities
S-1
Notice of Exempt Offering of Securities
No filings found
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-1MEF